Clinical similarity and biological diversity in the response to alprazolam in patients with panic disorder and generalized anxiety disorder

被引:14
|
作者
Klein, E
Zinder, O
Colin, V
Zilberman, I
Levy, N
Greenberg, A
Lenox, RH
机构
[1] RAMBAM MED CTR,LAB CLIN BIOCHEM,HAIFA,ISRAEL
[2] TECHNION IIT,RAPPAPORT FAC MED,HAIFA,ISRAEL
[3] UNIV FLORIDA,DEPT PSYCHIAT,GAINESVILLE,FL 32611
关键词
panic disorder; generalized anxiety disorder; alprazolam; cortisol; catecholamine;
D O I
10.1111/j.1600-0447.1995.tb09604.x
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Thirty-six patients with panic disorder (PD) and 35 patients with generalized anxiety disorder (GAD) participated in an open alprazolam treatment phase that preceded controlled withdrawal from alprazolam. Clinical ratings, blood pressure and heart rate were obtained along with plasma measurements of cortisol, ACTH, growth hormone and catecholamines. A similar clinical response profile was evident in both groups with rapid onset of improvement within the first week. The two diagnostic groups differed in their biological response to alprazolam. PD patients had a significant reduction in blood pressure, plasma cortisol and a trend toward significant reduction in plasma epinephrine, which were not seen in the GAD patients. GAD patients showed a significant reduction in plasma norepinephrine. These findings provide further evidence that PD and GAD are biologically distinct syndromes.
引用
收藏
页码:399 / 408
页数:10
相关论文
共 50 条
  • [41] Evaluation of Coronavirus Anxiety Levels and Coping Strategies of Major Depressive Disorder, Generalized Anxiety Disorder, and Panic Disorder Patients During the Covid-19 Pandemic
    Erden, Selime Celik
    Uygur, Abdullah Burak
    Karakus, Kadir
    MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2023, 57 (01): : 33 - 45
  • [42] Biological and Clinical Markers in Panic Disorder
    Cosci, Fiammetta
    Mansueto, Giovanni
    PSYCHIATRY INVESTIGATION, 2019, 16 (01) : 27 - 36
  • [43] Distinguishing generalized anxiety disorder, panic disorder, and mixed anxiety states in older treatment-seeking adults
    Mohlman, J
    de Jesus, M
    Gorenstein, EE
    Kleber, M
    Gorman, JM
    Papp, LA
    JOURNAL OF ANXIETY DISORDERS, 2004, 18 (03) : 275 - 290
  • [44] Two-Year Course of Generalized Anxiety Disorder, Social Anxiety Disorder, and Panic Disorder in a Longitudinal Sample of African American Adults
    Sibrava, Nicholas J.
    Beard, Courtney
    Bjornsson, Andri S.
    Moitra, Ethan
    Weisberg, Risa B.
    Keller, Martin B.
    JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2013, 81 (06) : 1052 - 1062
  • [45] Intrinsic Network Brain Dysfunction Correlates With Temporal Complexity in Generalized Anxiety Disorder and Panic Disorder
    Xu, Li
    Xu, Huazhen
    Ding, Huachen
    Li, Jinyang
    Wang, Chun
    FRONTIERS IN HUMAN NEUROSCIENCE, 2021, 15
  • [46] Biological markers of generalized anxiety disorder
    Maron, Eduard
    Nutt, David
    DIALOGUES IN CLINICAL NEUROSCIENCE, 2017, 19 (02) : 147 - 157
  • [47] Thiol-disulphide homeostasis in patients with general anxiety disorder and panic disorder
    Sahin, Esra Kabadayi
    Turan, Gokcen
    Neselioglu, Salim
    Can, Serdar Suleyman
    Atagun, Murat Ilhan
    DUSUNEN ADAM-JOURNAL OF PSYCHIATRY AND NEUROLOGICAL SCIENCES, 2019, 32 (04) : 289 - 294
  • [48] Differences in latency to first pharmacological treatment (duration of untreated illness) in anxiety disorders: a study on patients with panic disorder, generalized anxiety disorder and obsessive-compulsive disorder
    Dell'Osso, Bernardo
    Camuri, Giulia
    Benatti, Beatrice
    Buoli, Massimiliano
    Altamura, A. Carlo
    EARLY INTERVENTION IN PSYCHIATRY, 2013, 7 (04) : 374 - 380
  • [49] Which factors influence onset and latency to treatment in generalized anxiety disorder, panic disorder, and obsessive-compulsive disorder?
    Benatti, Beatrice
    Camuri, Giulia
    Dell'Osso, Bernardo
    Cremaschi, Laura
    Sembira, Ester
    Palazzo, Carlotta
    Oldani, Lucio
    Dobrea, Cristina
    Arici, Chiara
    Primavera, Diego
    Carpiniello, Bernardo
    Castellano, Filippo
    Carra, Giuseppe
    Clerici, Massimo
    Baldwin, David S.
    Altamura, Alfredo Carlo
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2016, 31 (06) : 347 - 352
  • [50] Ischemia modified albumin: A potential marker for global metabolic risk in generalized anxiety disorder and panic disorder
    Sahin, Esra Kabadayi
    Turan, Gokcen
    Neselioglu, Salim
    Atagun, Murat Ilhan
    KLINIK PSIKIYATRI DERGISI-TURKISH JOURNAL OF CLINICAL PSYCHIATRY, 2021, 24 (02): : 153 - 159